India, Aug. 1 -- India's healthcare and life sciences sector is entering a new phase of growth. Emerging healthcare companies are increasingly employing acquisitions as a business strategy to expand faster, bolster their capacities and establish market leadership. According to an EY report, the sector recorded Rs 10,000 crore worth of announced transactions across hospitals, diagnostics and specialty care in Q2 FY26 alone.

While deal activity has accelerated across the ecosystem, the more significant shift is who is driving it. Acquisitions are no longer the territory of large healthcare conglomerates; they are becoming an important growth tool for founder-led healthcare businesses to build capabilities.

Healthcare organisations have hi...